Skip to content

Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

Nippon Chemiphar

日本ケミファ

4539 · TSE · Pharmaceutical

Financials Consolidated

Revenue¥33.1bn+1.6% year on yearConsolidated · FY3/26

Ordinary profit¥227m−48.8% year on yearConsolidated · FY3/26

Net profit¥198m−32.7% year on yearConsolidated · FY3/26

Dividend per share¥50.00FY3/26

Performance over time

Revenue
¥32.5bnFY3/22
¥31.6bnFY3/23
¥30.7bnFY3/24
¥32.6bnFY3/25
¥33.1bnFY3/26
Ordinary profit
¥1.02bnFY3/22
¥58.0mFY3/23
−¥219mFY3/24
¥443mFY3/25
¥227mFY3/26
Net profit (attributable)
¥700mFY3/22
¥339mFY3/23
−¥180mFY3/24
¥294mFY3/25
¥198mFY3/26
Op. cash flow
¥1.80bnFY3/22
−¥916mFY3/23
¥296mFY3/24
−¥265mFY3/25
¥620mFY3/26

People & pay

Employees, whole group878 peopleFY3/26

Employees, parent company (non-consolidated)331 peopleFY3/26

Average salary¥7.50mFY3/26

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitNet profit (attributable)EPSDividendTotal assetsNet assetsOp. cash flow
FY3/26¥33.1bn+1.6% year on year¥227.0m¥198m¥54.81¥50.00¥50.0bn¥19.5bn¥620m
FY3/25¥32.6bn+5.9% year on year¥443.0m¥294m¥81.72¥50.00¥49.9bn¥19.2bn−¥265m
FY3/24¥30.7bn−2.6% year on year−¥219.0m−¥180m−¥50.14¥50.00¥49.5bn¥18.5bn¥296m
FY3/23¥31.6bn−2.9% year on year¥58.0m¥339m¥94.07¥50.00¥48.6bn¥18.5bn−¥916m
FY3/22¥32.5bn¥1,022.0m¥700m¥194.33¥50.00¥49.5bn¥18.5bn¥1,801m

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100YBOB · Japan GAAP. Each figure's years come from one report's five-year summary.